Knight Cns

  Address - Canada

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 11265062

  Document Type - Tender Notices

Description - Project Number: 45104Company Name: KNIGHT THERAPEUTICS INC.Date SPI Disclosed: Nov 22, 2022Country: Latin America RegionRegion: Latin America and the CaribbeanProjected Board Date: Jul 1, 2021Environmental Category: BStatus: ActiveDepartment: CM1M7 - Regional Industry - MAS LAC/MAS Health & Education - LACProject DescriptionIFC is considering providing an up to US$40 million loan to Knight Therapeutics Inc. ( Knight or the Company ), a pan-American (ex-USA) specialty pharmaceutical company headquartered in Canada with significant operations in Latin America, to partially finance the acquisition of the rights to manufacture, market and sell Exelon® (rivastigmine) in Canada and Latin America

Mt Ref Id - 11265062

Deadline - Dec 31, 2023